Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Acad Emerg Med. 2019 Jul 18;26(12):1346–1356. doi: 10.1111/acem.13815

Table 3.

Fluid Administration During Intervention Window

Variable LR Group NS Group Difference (95% CI)
Total crystalloid volumes administered
 Crystalloid fluid volume (mL/kg)
  Total fluid 107 (60 to 155) 98 (63 to 128) −9 (−57 to 35)
  Bolus fluid
   Prerandomization 20 (19 to 23) 20 (17 to 27) 0 (−1 to 4)
   Postrandomization 38 (20 to 60) 33 (20 to 40) −5 (−28 to 18)
  Maintenance fluid
   Total 49 (18 to 88) 35 (24 to 78) −14 (−50 to 18)
   NS 0 (0 to 0) 21 (2 to 41) 21 (4 to 39)
   LR 40 (9 to 78) 0 (0 to 0) −40 (−68 to −11)
   Other 0 (0 to 0) 0 (0 to 21) 0 (0 to 17)
 Proportion of patients receiving ≥60 mL/kg as bolus fluid 9 (38) 11 (42)
Adherence to study arm
 Fluid compliance among isotonic fluidsa,b
  Pre- and postrandomization fluidc 15 (63) 23 (88)
  Postrandomization fluid 20 (83) 24 (92)
 Proportion of isotonic fluid as NS
  Pre- and postrandomizationc 20 (13 to 35) 100 (100 to 100) 80 (69 to 85)
  Postrandomization 0 (0 to 0) 100 (100 to 100) 100 (100 to 100)
 Proportion of isotonic fluid as LR
  Pre- and postrandomization 80 (65 to 87) 0 (0 to 0) −80 (−85 to −69)
  Postrandomization 100 (100 to 100) 0 (0 to 0) −100 (−100 to −100)

Data are reported as n (%) or median (IQR).

IQR = interquartile range; LR = lactated Ringer’s; NS = 0.9% normal saline.

a

Fluid compliance was defined as receipt of ≥75% of study fluid as LR in LR group and ≥90% of study fluid as NS in NS group.

b

Isotonic fluids included LR, NS, D5 LR, or D5 NS with additional electrolytes permitted as per clinical team.

c

Elements that were determined a priori as feasibility metrics.